Stellantis Turnaround Strategy Prediction Market Oversight and Oura IPO Filing Highlight Key Market Developments Nifty Midcap 100 Hits Record High for Fourth Straight Session Analysts Flag Potential 20 Upside Title Tech Surge Powers SP 500 Higher as Energy Weighs Steel Stocks Rally as Government Extends Minimum Import Price on 66 Steel Products Oil Prices Decline as USIran Talks Spur Hope for Hormuz Strait Deescalation Kars4Kids Ad Ban in California Highlights Regulatory Risks for Nonprofit Advertising FUBO Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher BRZE Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Optimism DOYU Q4 2025 Earnings Earnings Beat Estimates by Wide Margin Revenue Details Pending ARDT Q1 2026 Earnings EPS Surges Past Estimates with 486 Beat Collegium Pharmaceutical Q1 2026 Earnings EPS Surpasses Estimates Amid Strategic Execution XPO Q1 2026 Earnings Earnings Surpass Estimates as Profitability Improves Blue Bird Corporation BLBD Edges Lower Amid Market Consolidation QTWO Retreats from Resistance Q2 Holdings Slips 167 as Support Levels Come into Focus Spectral AI Inc Warrants MDAIW Hold Steady Near Support After Flat Session Melar Acquisition Corp I Warrant MACIW Holds Near Support Amidst Low Volume Trading Worthington Enterprises WOR Holds Ground Near Support Amid Modest Pullback Trump Maintains Iran Naval Blockade Signals No Rush for Deal WEBTOON Entertainment WBTN Q1 2026 Earnings Loss Narrows Sharply Shares Edge Higher Banco Bradesco BBD Edges Higher as Support Holds Key Levels to Watch ROIV Q1 2026 Earnings WiderThanExpected Loss Highlights PreRevenue Pipeline Costs IMVT Q1 2026 Earnings EPS Misses Estimates Stock Slightly Positive Amid Development Progress Kratos Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Greenidge Generation Holdings 850 Senior Notes GREEL Q1 2025 Earnings Narrowed Loss Exceeds Expectations as Stock Reacts Cautiously Insperity Q1 2026 Earnings EPS Surpasses Estimates by 511 KHC Q1 2026 Earnings Earnings Beat Boosts Sentiment Amid Revenue Uncertainty MiNK Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Expectations Amid Clinical Progress